Preimplantation Genetic Testing Market Overview
Continuous technical progress in the field of single cell testing has significantly changed the way preimplantation genetics market works. The technology has led to high levels of accuracy and efficiency. The idea of selecting enhanced genetic traits through genetic testing has raised concerns. People think that if parents are allowed to choose the traits, they will somehow take their children’s right to an open future away from them. People have also raised concerns regarding the riches having more advantages in terms of genetic benefits. These are some of the factors that could affect the preimplantation genetic testing market growth.
Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/8121
Preimplantation diagnosis means the diagnosis can be carried out in connection with in vitro fertilization when the pre-embryo is implanted in the uterus of a woman. For families with a history of several sex-linked diseases, preimplantation genetic diagnosis can help prevent the birth of child with such a disease. As a result, pregnancies could be normal so that the woman won’t have to abort the fetus any time at a later stage. In this way, people can also stop giving birth to a child with a very serious disease.
Preimplantation genetic diagnosis is rapidly becoming a mainstream medical practice in many countries. As per a preimplantation genetic testing market research report, the market, in terms of value, stood at US$375.8 million in 2018. Analysts have predicted the future growth of the market during the forecast period till 2025 and have revealed that the global market for preimplantation genetic testing market is set to register a CAGR of 10.2% during this period.
Preimplantation Genetic Testing Market Regional Overview
In the global preimplantation genetic testing market report, segments mentioned above are also covered into major regions – the Americas, Asia-Pacific, Europe, and the Middle East and Africa. The market in the Americas has been segmented into South America and North America with subsegments like the US and Canada. The preimplantation genetic testing market in Europe has been segmented into Eastern and Western Europe. In these regions, markets across Germany, the UK, France, Italy, Spain, and the rest of Western Europe are covered. The market for preimplantation genetic testing in Asia-Pacific has been segmented into Australia, China, India, Japan, South Korea, and the rest of Asia-Pacific. The Preimplantation Genetic Testing market has been segmented into the Middle East and Africa.
Preimplantation Genetic Testing Market Segmentation
The global market for preimplantation genetic testing has been segmented into different categories to understand and analyse the market at different levels. The market has been segmented into different types, procedures, applications, end user, services, products, and technologies. Based on type, the market is divided into X-linked diseases, chromosomal abnormalities, embryo testing, LA typing, aneuploidy screening, and others. Based on application it is further segmented into late-onset genetic disorders, embryo HLA typing for stem cell therapy prognosis, inherited the genetic disease, and others. On the basis of technology, the market has been segmented into polymerase chain reaction, next-generation sequencing, fluorescence in situ hybridization, single-nucleotide polymorphism, and comparative genomic hybridization. Based on products and services, the market for preimplantation genetic testing is divided into instruments, software, reagents and consumables, and services. By end user the market has been segmented into hospitals, maternity centers & fertility clinics, academic institutes, and diagnostic labs and research laboratories.
Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/preimplantation-genetic-testing-market-8121
Preimplantation Genetic Testing Industry News
Recent studies show how embryos can shed their DNA, that too into the media where they grow. Significant improvements in testing have also been widely discussed by people. Scientists believe that in a few years, people may no longer need to go for biopsy embryos in order to perform preimplantation genetic testing. The notion is that PGT-A can become a routine part of IVF cycles.
Browse More Related Reports at:
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.